Asterias Biotherapeutics, Inc. (NYSE: AST) announced the appointment of pharmaceutical industry veteran Stephen L. Cartt as President and Chief ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE